ES2106770T3 - Compuestos difenilicos como inhibidores del metabolismo del acido araquidonico y su empleo en composiciones farmaceuticas. - Google Patents

Compuestos difenilicos como inhibidores del metabolismo del acido araquidonico y su empleo en composiciones farmaceuticas.

Info

Publication number
ES2106770T3
ES2106770T3 ES91810685T ES91810685T ES2106770T3 ES 2106770 T3 ES2106770 T3 ES 2106770T3 ES 91810685 T ES91810685 T ES 91810685T ES 91810685 T ES91810685 T ES 91810685T ES 2106770 T3 ES2106770 T3 ES 2106770T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
diphenilic
metabolism
inhibitors
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91810685T
Other languages
English (en)
Inventor
Tankred Prof Dr Schewe
Helmut Dr Luther
Dentscho Dr Jordanov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba Spezialitaetenchemie Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba Spezialitaetenchemie Holding AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2106770T3 publication Critical patent/ES2106770T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065—Diphenyl-substituted acyclic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/06—Phenols the aromatic ring being substituted by nitro groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LAS COMPOSICIONES FARMACEUTICAS CONTIENEN UNA COMBINACION DE LA FORMULA I DONDE X SIGNIFICA OXIGENO, AZUFRE O -CH SUB 2-, Y, CLORO, BROMO Y Z LOS RESTOS DE SO SUB 2H, NO SUB 2 O ALQUILO DE C SUB 1-C SUB 4 Y R REPRESENTA LOS NUMEROS DE 0 A 3, O REPRESENTA LOS NUMEROS DE 0 A 3, P LOS NUMEROS DE 0 A 1, M LOS NUMEROS DE 1 A 2 Y N DE 0 A 1 Y TIENEN EFECTOS EFICACES QUE PARALIZAN LA SINTESIS H DE LIPOXIGENASE Y PROSTAGLANDIN. SE PUEDE UTILIZAR EN FORMA DE EMULSIONES, SALVAS, GELES, SPRAY Y POLVOS, ENTRE OTROS. PARA EL TRATAMIENTO LOCAL O INHALATIVO DE ENFERMEDADES INFLAMATORIAS, ALERGICAS O ESPASMOLITICAS O ENFERMEDADES DE SORIASIS, ASMAS BRONQUIALES O ENFERMEDADES CON INTERFERENCIAS DE LA PROLIFERACION DE LAS CELULAS.
ES91810685T 1990-09-05 1991-08-27 Compuestos difenilicos como inhibidores del metabolismo del acido araquidonico y su empleo en composiciones farmaceuticas. Expired - Lifetime ES2106770T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH287590 1990-09-05

Publications (1)

Publication Number Publication Date
ES2106770T3 true ES2106770T3 (es) 1997-11-16

Family

ID=4243541

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91810685T Expired - Lifetime ES2106770T3 (es) 1990-09-05 1991-08-27 Compuestos difenilicos como inhibidores del metabolismo del acido araquidonico y su empleo en composiciones farmaceuticas.

Country Status (22)

Country Link
US (1) US5185377A (es)
EP (1) EP0474597B1 (es)
JP (1) JP3264950B2 (es)
KR (1) KR100201749B1 (es)
AT (1) ATE156353T1 (es)
AU (1) AU645599B2 (es)
CA (1) CA2050569C (es)
CZ (1) CZ279624B6 (es)
DE (1) DE59108814D1 (es)
DK (1) DK0474597T3 (es)
ES (1) ES2106770T3 (es)
FI (1) FI914185A (es)
GR (1) GR3024440T3 (es)
HU (2) HUT58998A (es)
IE (1) IE913110A1 (es)
IL (1) IL99376A (es)
MX (1) MX9100917A (es)
NO (1) NO913472L (es)
PT (1) PT98874B (es)
RU (1) RU2060731C1 (es)
SK (1) SK279104B6 (es)
ZA (1) ZA917005B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9117140D0 (en) * 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
US6440395B1 (en) 1992-06-22 2002-08-27 Barry M. Libin Antiplaque mouth rinse
CH686285A5 (fr) * 1992-08-06 1996-02-29 Beiersdorf Ag Preparation cosmetique ou pharmaceutique servant a retarder le vieillissement de la peau humaine.
US5880146A (en) * 1995-06-07 1999-03-09 Fuji Immunopharmaceuticals Corporation Inhibition of IL-12-induced IFN-γ synthesis by specific bis-phenol compounds as a method of immune modulation
AU6512296A (en) * 1995-07-20 1997-02-18 Uwe Juergens Use of a non-steroidal anti-inflammatory drug for topical and systemic treatment of acute and chronic polypoid rhinosinusitis
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6108850A (en) * 1997-06-03 2000-08-29 Mclaughlin; Gerald Accelerated method and instrumentation for whitening teeth
DE19834355A1 (de) * 1998-07-30 2000-02-03 Henkel Kgaa Entzündungshemmende Zahnpflegemittel
US7566740B2 (en) * 1998-10-06 2009-07-28 Bml Pharmaceuticals, Inc. Method of treating mucositis
EP1137386B8 (en) * 1999-06-23 2006-12-13 Jawaharlal Nehru Centre For Advanced Scientific Research Use of triclosan as an antimalarial agent
AU2002223958A1 (en) * 2000-12-20 2002-07-01 Warner-Lambert Company Llc Non-halogenated phenoxy and/or benzyloxy phenols and antimicrobial compositions containing them
US20030229149A1 (en) * 2002-05-28 2003-12-11 Werner Baschong Anti-inflammatory agents
EP1366763A1 (en) * 2002-05-28 2003-12-03 Ciba SC Holding AG Hydroxy diphenyl ether compounds as anti-inflammatory agents
WO2012018980A2 (en) * 2010-08-04 2012-02-09 Yun Michael Shim Compositions and methods for treating inflammatory diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1199273A (en) * 1982-07-15 1986-01-14 Ctibor Schindlery Anti-inflammatory composition
GB2148116B (en) * 1983-10-27 1986-07-30 Ciba Geigy Ag Topical steroid preparations
GB8526093D0 (en) * 1985-10-22 1985-11-27 Beecham Group Plc Composition
US4735802A (en) * 1986-05-05 1988-04-05 Le Bich N Topical dermatological composition and method of treatment
US4942029A (en) * 1986-09-19 1990-07-17 Smith & Nephew United, Inc. Medicated skin preparation
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
GB8718026D0 (en) * 1987-07-29 1987-09-03 Smith & Nephew Ass Pharmaceutical composition
AU610906B2 (en) * 1987-07-31 1991-05-30 Sumitomo Chemical Company, Limited Method for preventing harm from bloodsucking insects

Also Published As

Publication number Publication date
HU211292A9 (en) 1995-11-28
NO913472D0 (no) 1991-09-04
PT98874B (pt) 1999-02-26
CS271891A3 (en) 1992-03-18
CZ279624B6 (cs) 1995-05-17
GR3024440T3 (en) 1997-11-28
IL99376A0 (en) 1992-08-18
ZA917005B (en) 1992-04-29
PT98874A (pt) 1992-07-31
ATE156353T1 (de) 1997-08-15
FI914185A0 (fi) 1991-09-04
EP0474597A2 (de) 1992-03-11
IL99376A (en) 1996-01-19
SK279104B6 (sk) 1998-06-03
AU645599B2 (en) 1994-01-20
FI914185A (fi) 1992-03-06
EP0474597A3 (en) 1992-07-01
MX9100917A (es) 1992-05-04
CA2050569A1 (en) 1992-03-06
US5185377A (en) 1993-02-09
RU2060731C1 (ru) 1996-05-27
HUT58998A (en) 1992-04-28
DK0474597T3 (da) 1997-10-20
KR920005988A (ko) 1992-04-27
KR100201749B1 (ko) 1999-06-15
IE913110A1 (en) 1992-03-11
JPH04257517A (ja) 1992-09-11
CA2050569C (en) 2004-01-27
AU8364091A (en) 1992-03-12
EP0474597B1 (de) 1997-08-06
NO913472L (no) 1992-03-06
DE59108814D1 (de) 1997-09-11
JP3264950B2 (ja) 2002-03-11

Similar Documents

Publication Publication Date Title
ES2106770T3 (es) Compuestos difenilicos como inhibidores del metabolismo del acido araquidonico y su empleo en composiciones farmaceuticas.
SE9402558D0 (sv) Ny användning av azatricykloderivat och farmaceutiska kompositioner innehållande desamma
MX9405132A (es) Tetrahidro pirazolopiridinas biciclicas.
BR9810385A (pt) Derivados de ácido benzóico 2-(4-bromo ou 4-iodo fenilamino) e sua utilização como inibidores de mek
BR9307648A (pt) Pirazolopirimidinas como antagonistas de crf
FI843864L (fi) 2-amino-5-hydroxy-4 -metylpyrimidinderivat.
PT92821A (pt) Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa
ES2171174T3 (es) Derivados fenolicos de benzopirano para uso como agentes antibacterianos, antiviricos y de cicatrizacion de las heridas.
MX9200396A (es) Derivados de benciloxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DE69410081D1 (de) Zwischenprodukte für die Herstellung von Endothelinrezeptor-Antagonist-Triterpen-Derivaten
FI844225L (fi) Griseolinsyraderivat och deras anvaendning.
AR001769A1 (es) Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación
PE26691A1 (es) Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas
ES2062407T3 (es) Compuestos de 2-hidroxi-3-fenoxipropilamino.
ES2108977T3 (es) Derivados del acido hidroximetilfurazanocarboxilico y su utilizacion en el tratamiento de enfermedades cardiovasculares.
ES2063578T3 (es) Derivados del acido hidroxamico y de n-hidroxiurea inhibidores de la lipoxigenasa.
ES2138366T3 (es) Indol carbamatos como antagonistas de leucotrienos.
ES2112832T3 (es) Derivados carbamoilicos.
ES8302715A1 (es) Un procedimiento para la preparacion de benzopiranotriazoles antialergicos.
PE20001232A1 (es) Compuestos derivados de quinolina y su uso terapeutico
ES531480A0 (es) Derivados del acido d-2-(6-metoxi-2-naftil)-propionico
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
FI981521A0 (fi) Substituoidut beta-diketonit ja niiden käyttö
DE502004004660D1 (de) Zusammensetzung aus alkandicarbonsäuren und einem pharmazeutischen wirkstoff
PT94243A (pt) Processo para preparacao de inibidores beta-lactamicos de elastase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 474597

Country of ref document: ES